Amphastar Pharma (AMPH)

$26.75 +0.23 (0.87%)
Market Cap 1.23B
Revenue (ttm) 731.97M
Net Income (ttm) 159.52M
EPS (ttm) N/A
PE Ratio 8.82
Forward PE 8.74
Profit Margin 21.79%
Debt to Equity Ratio 0.80
Volume 331,000
Avg Vol 524,736
Day's Range N/A - N/A
Shares Out 46.50M
Stochastic %K 35%
Beta 0.75
Analysts Sell
Price Target $32.67

Company Profile

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a nasal spray for the treatment of severe hypoglycemia; Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin to prevent and treat deep vein thrombosis; REXTOVY and Naloxon...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 909 980 9484
Address:
11570 6th Street, Rancho Cucamonga, United States
Arcides
Arcides Oct. 3 at 3:57 PM
$AMPH this was clearly rejected at 200dma, 10, 21 and 200 days moving averages are pointing down, 50dma points up will it hold that level for a while or break down again?
0 · Reply
NYBomba
NYBomba Oct. 1 at 5:21 PM
$AMPH - incoming Golden Cross, should happen by Monday, GLTA
0 · Reply
highnihilism
highnihilism Oct. 1 at 11:32 AM
$IMMP Immutep Trades: 16 | Total $: 2.9 K | 1.72 × 90-Day Avg $: 1.7 K | Call $: 636 | Put $: 2.3 K | Single-Leg: 74% | Multi-Leg: 26% | Contingent: – $CDNA CareDx Trades: 5 | Total $: 46 K | 1.61 × 90-Day Avg $: 28.6 K | Call $: 635 | Put $: 45.4 K | Single-Leg: 1% | Multi-Leg: 99% | Contingent: – $AMPH Amphastar Pharmaceuticals Trades: 2 | Total $: 27.2 K | 1.80 × 90-Day Avg $: 15.1 K | Call $: 630 | Put $: 26.6 K | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $CASH Pathward Financial Trades: 4 | Total $: 1.6 K | 0.05 × 90-Day Avg $: 33.7 K | Call $: 630 | Put $: 1 K | Single-Leg: 100% | Multi-Leg: 0% | Contingent: –
0 · Reply
highnihilism
highnihilism Sep. 17 at 9:54 AM
IWM: Russell 2000 → $TBPH Theravance Biopharma $ZGN Ermenegildo Zegna $HLLY Holley $THS Treehouse Foods $AMPH Amphastar Pharmaceuticals
0 · Reply
EquityInvest
EquityInvest Sep. 15 at 3:15 PM
$AMPH short!!!!
0 · Reply
FloatWanderer
FloatWanderer Sep. 15 at 6:36 AM
$AMPH Earnings variability expected; long-term thesis hinges on scale
0 · Reply
TalkMarkets
TalkMarkets Sep. 12 at 6:33 PM
#Volatility Ahead? Asset Managers Are Shorting The S&P 500 $SMCI $SPY $AMPH $WING $HIMS https://talkmarkets.com/content/etfs/volatility-ahead-asset-managers-are-shorting-the-sp-500?post=522515
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 5 at 9:44 PM
$AMPH Excellent article that nails exactly where AMPH stands right now. So if you want to update your AMPH knowledge or get acquainted with AMPH, this is a must read. https://beyondspx.com/quote/AMPH/amphastar-s-strategic-ascent-branded-powerhouses-and-a-robust-pipeline-drive-future-growth-nasdaq-amph#analysis
0 · Reply
NYBomba
NYBomba Sep. 2 at 5:23 PM
$AMPH - great looking chart, just on technicals, I'd say the price range will step higher ...
0 · Reply
BigSqueezeComing
BigSqueezeComing Sep. 2 at 8:11 AM
$AMPH Amphastar Pharmaceuticals, Inc. (AMPH) Secures FDA Approval for Generic Iron Sucrose Injection By Laiba Immad | September 02, 2025, 4:06 AM
0 · Reply
Latest News on AMPH
After Protracted Sell-Off, Amphastar Looks Like A Value Pick

Sep 23, 2025, 10:06 AM EDT - 11 days ago

After Protracted Sell-Off, Amphastar Looks Like A Value Pick

Amphastar Pharmaceuticals to Present at the 2025 Wells Fargo Healthcare Conference

Aug 28, 2025, 6:00 AM EDT - 5 weeks ago

Amphastar Pharmaceuticals to Present at the 2025 Wells Fargo Healthcare Conference

Amphastar Secures FDA Nod For Iron Sucrose Injection, Analysts Eye Major Sales Momentum

Aug 12, 2025, 1:38 PM EDT - 7 weeks ago

Amphastar Secures FDA Nod For Iron Sucrose Injection, Analysts Eye Major Sales Momentum

Amphastar Pharmaceuticals Bolsters Proprietary Pipeline Through Exclusive Licensing Agreement with Nanjing Anji Biotechnology Co., Ltd.

Aug 12, 2025, 6:00 AM EDT - 7 weeks ago

Amphastar Pharmaceuticals Bolsters Proprietary Pipeline Through Exclusive Licensing Agreement with Nanjing Anji Biotechnology Co., Ltd.

Amphastar Announces FDA Approval for Iron Sucrose Injection, USP

Aug 11, 2025, 6:00 AM EDT - 7 weeks ago

Amphastar Announces FDA Approval for Iron Sucrose Injection, USP

Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 1:40 AM EDT - 2 months ago

Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2025 Earnings Call Transcript

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2025

Aug 7, 2025, 4:05 PM EDT - 2 months ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2025

Amphastar Pharmaceuticals: Shares Are Interesting, And Options Even More

Jul 29, 2025, 9:12 AM EDT - 2 months ago

Amphastar Pharmaceuticals: Shares Are Interesting, And Options Even More

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7th, 2025

Jul 29, 2025, 6:00 AM EDT - 2 months ago

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7th, 2025

Amphastar Pharmaceuticals Aims to Quadruple Domestic Manufacturing Capacity at Rancho Cucamonga Headquarters

Jul 14, 2025, 4:05 PM EDT - 2 months ago

Amphastar Pharmaceuticals Aims to Quadruple Domestic Manufacturing Capacity at Rancho Cucamonga Headquarters

Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

May 22, 2025, 6:00 AM EDT - 4 months ago

Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

Amphastar Pharmaceuticals: Navigating Through An Inflection Year

May 11, 2025, 11:32 AM EDT - 5 months ago

Amphastar Pharmaceuticals: Navigating Through An Inflection Year

Amphastar Pharmaceuticals to Present at the 2025 Bank of America Health Care Conference

May 9, 2025, 6:00 AM EDT - 5 months ago

Amphastar Pharmaceuticals to Present at the 2025 Bank of America Health Care Conference

Amphastar Pharmaceuticals Inc. (AMPH) Q1 2025 Earnings Call Transcript

May 7, 2025, 7:20 PM EDT - 5 months ago

Amphastar Pharmaceuticals Inc. (AMPH) Q1 2025 Earnings Call Transcript

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025

May 7, 2025, 4:05 PM EDT - 5 months ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2025

Apr 30, 2025, 6:00 AM EDT - 5 months ago

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2025

Amphastar Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference

Apr 3, 2025, 6:00 AM EDT - 6 months ago

Amphastar Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference

International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award

Mar 28, 2025, 6:00 AM EDT - 6 months ago

International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award

Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference

Mar 5, 2025, 6:00 AM EST - 7 months ago

Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference

Specialty Pharma Amphastar Stock Falls On Lower Than Expected Q4 Earnings, Analyst Sees Competitive Headwinds

Feb 28, 2025, 2:15 PM EST - 7 months ago

Specialty Pharma Amphastar Stock Falls On Lower Than Expected Q4 Earnings, Analyst Sees Competitive Headwinds

Amphastar Pharmaceuticals Inc. (AMPH) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 11:04 PM EST - 7 months ago

Amphastar Pharmaceuticals Inc. (AMPH) Q4 2024 Earnings Call Transcript

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2024

Feb 27, 2025, 4:05 PM EST - 7 months ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2024

Top 2 Health Care Stocks That May Rocket Higher This Month

Feb 21, 2025, 2:17 PM EST - 8 months ago

Top 2 Health Care Stocks That May Rocket Higher This Month

WST

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 27, 2025

Feb 20, 2025, 4:05 PM EST - 8 months ago

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 27, 2025

Amphastar Pharmaceuticals: A Gradual Strategy

Feb 19, 2025, 1:09 PM EST - 8 months ago

Amphastar Pharmaceuticals: A Gradual Strategy

Amphastar Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 8, 2025, 6:00 AM EST - 9 months ago

Amphastar Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Amphastar Pharmaceuticals: Cheap With Caveats

Jan 3, 2025, 12:48 PM EST - 9 months ago

Amphastar Pharmaceuticals: Cheap With Caveats

Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare Conference

Nov 26, 2024, 4:05 PM EST - 11 months ago

Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare Conference

Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference

Nov 13, 2024, 4:05 PM EST - 11 months ago

Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference

Amphastar Pharmaceuticals Inc. (AMPH) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 9:12 PM EST - 11 months ago

Amphastar Pharmaceuticals Inc. (AMPH) Q3 2024 Earnings Call Transcript

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024

Nov 6, 2024, 4:05 PM EST - 11 months ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6, 2024

Oct 29, 2024, 6:00 AM EDT - 1 year ago

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6, 2024

Amphastar Pharmaceuticals Inc (AMPH) Trading Down 3.54% on Oct 2

Oct 2, 2024, 12:08 PM EDT - 1 year ago

Amphastar Pharmaceuticals Inc (AMPH) Trading Down 3.54% on Oct 2

Amphastar Pharmaceuticals Offers Interesting Growth And Income Prospects

Sep 13, 2024, 7:20 AM EDT - 1 year ago

Amphastar Pharmaceuticals Offers Interesting Growth And Income Prospects

Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference

Aug 28, 2024, 4:10 PM EDT - 1 year ago

Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference

6 Beaten Down Stocks Rated Buy (SA Quant)

Aug 19, 2024, 5:00 AM EDT - 1 year ago

6 Beaten Down Stocks Rated Buy (SA Quant)

CAAP CCL STRL TCOM TWLO

Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2024 Earnings Call Transcript

Aug 9, 2024, 7:47 PM EDT - 1 year ago

Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2024 Earnings Call Transcript

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2024

Aug 7, 2024, 4:05 PM EDT - 1 year ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2024

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7, 2024

Jul 31, 2024, 4:05 PM EDT - 1 year ago

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7, 2024

BetterInvesting™ Magazine Update on Amphastar Pharmaceuticals Inc. and Medtronic PLC

Jun 14, 2024, 4:30 PM EDT - 1 year ago

BetterInvesting™ Magazine Update on Amphastar Pharmaceuticals Inc. and Medtronic PLC

MDT

Arcides
Arcides Oct. 3 at 3:57 PM
$AMPH this was clearly rejected at 200dma, 10, 21 and 200 days moving averages are pointing down, 50dma points up will it hold that level for a while or break down again?
0 · Reply
NYBomba
NYBomba Oct. 1 at 5:21 PM
$AMPH - incoming Golden Cross, should happen by Monday, GLTA
0 · Reply
highnihilism
highnihilism Oct. 1 at 11:32 AM
$IMMP Immutep Trades: 16 | Total $: 2.9 K | 1.72 × 90-Day Avg $: 1.7 K | Call $: 636 | Put $: 2.3 K | Single-Leg: 74% | Multi-Leg: 26% | Contingent: – $CDNA CareDx Trades: 5 | Total $: 46 K | 1.61 × 90-Day Avg $: 28.6 K | Call $: 635 | Put $: 45.4 K | Single-Leg: 1% | Multi-Leg: 99% | Contingent: – $AMPH Amphastar Pharmaceuticals Trades: 2 | Total $: 27.2 K | 1.80 × 90-Day Avg $: 15.1 K | Call $: 630 | Put $: 26.6 K | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $CASH Pathward Financial Trades: 4 | Total $: 1.6 K | 0.05 × 90-Day Avg $: 33.7 K | Call $: 630 | Put $: 1 K | Single-Leg: 100% | Multi-Leg: 0% | Contingent: –
0 · Reply
highnihilism
highnihilism Sep. 17 at 9:54 AM
IWM: Russell 2000 → $TBPH Theravance Biopharma $ZGN Ermenegildo Zegna $HLLY Holley $THS Treehouse Foods $AMPH Amphastar Pharmaceuticals
0 · Reply
EquityInvest
EquityInvest Sep. 15 at 3:15 PM
$AMPH short!!!!
0 · Reply
FloatWanderer
FloatWanderer Sep. 15 at 6:36 AM
$AMPH Earnings variability expected; long-term thesis hinges on scale
0 · Reply
TalkMarkets
TalkMarkets Sep. 12 at 6:33 PM
#Volatility Ahead? Asset Managers Are Shorting The S&P 500 $SMCI $SPY $AMPH $WING $HIMS https://talkmarkets.com/content/etfs/volatility-ahead-asset-managers-are-shorting-the-sp-500?post=522515
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 5 at 9:44 PM
$AMPH Excellent article that nails exactly where AMPH stands right now. So if you want to update your AMPH knowledge or get acquainted with AMPH, this is a must read. https://beyondspx.com/quote/AMPH/amphastar-s-strategic-ascent-branded-powerhouses-and-a-robust-pipeline-drive-future-growth-nasdaq-amph#analysis
0 · Reply
NYBomba
NYBomba Sep. 2 at 5:23 PM
$AMPH - great looking chart, just on technicals, I'd say the price range will step higher ...
0 · Reply
BigSqueezeComing
BigSqueezeComing Sep. 2 at 8:11 AM
$AMPH Amphastar Pharmaceuticals, Inc. (AMPH) Secures FDA Approval for Generic Iron Sucrose Injection By Laiba Immad | September 02, 2025, 4:06 AM
0 · Reply
JarvisFlow
JarvisFlow Aug. 26 at 3:23 PM
B of A Securities has updated their rating for Amphastar Pharma ( $AMPH ) to Neutral with a price target of 32.
0 · Reply
PatternWatcher
PatternWatcher Aug. 23 at 5:31 AM
$AMPH Amphastar Pharmaceuticals produces generic injectables facing pricing pressure and regulatory scrutiny
0 · Reply
OpenOutcrier
OpenOutcrier Aug. 18 at 1:24 PM
$AMPH Amphenol to Buy Trexon From Audax Private Equity for $1 Billion - WSJ https://ooc.bz/l/74299
0 · Reply
SmartMoneyTradez
SmartMoneyTradez Aug. 12 at 8:02 PM
$AMPH someone has been buying
0 · Reply
Estimize
Estimize Aug. 12 at 8:00 PM
Wall St is expecting 0.86 EPS for $AMPH Q3 [Reporting 11/10 AMC] http://www.estimize.com/intro/amph?chart=historical&metric_name=eps&utm_co
0 · Reply
topstockalerts
topstockalerts Aug. 12 at 1:30 PM
$AMPH she wants to move higher..
0 · Reply
JarvisFlow
JarvisFlow Aug. 12 at 12:30 PM
Needham updates rating for Amphastar Pharma ( $AMPH ) to Buy, target set at 36.
0 · Reply
OpenOutcrier
OpenOutcrier Aug. 12 at 12:24 PM
$AMPH (+4.8% pre) Amphastar licenses three peptide drugs from Nanjing Anji for $453 million - SI https://ooc.bz/l/73591
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Aug. 12 at 10:13 AM
WATCHLIST AUG 12 2025 $ALGT Allegiant Expands Growing Network With New Service To Huntsville International Airport And Multiple Florida Destinations $SMR Canaccord Genuity Maintains Buy on NuScale Power, Raises Price Target to $44 $KLTO Klotho Neurosciences (KLTO) Begins KLTO-202 Gene Therapy Manufacturing Using AAVnerGene's AAVone And ATHENA Platform Technologies $AMPH Amphastar Pharmaceuticals Signs $453M Exclusive Licensing Deal With Nanjing Anji For Three Proprietary Peptides In Oncology And Ophthalmology $HITI High Tide (HITI) Updates On German Medical Cannabis Deal, Appoints VP Digital & eCommerce, Files C$100M Shelf Prospectus, Hires IR Agency
0 · Reply
EquityInvest
EquityInvest Aug. 12 at 1:00 AM
First generic of Daiichi's Venofer approved in US | FirstWord Pharma $AMPH Wish I would have seen this before AMPH is such a deceptive company. They did not disclose this other approval that gets exclusivity. Should sue for misrepresentation. https://firstwordpharma.com/story/5988088
0 · Reply
LewisDaKat
LewisDaKat Aug. 11 at 7:25 PM
News Amphastar Announces FDA Approval for Iron Sucrose Injection, USP https://marketwirenews.com/news-releases/amphastar-announces-fda-approval-for-iron-sucrose-in-8360497637632681.html $AMPH
0 · Reply
EquityInvest
EquityInvest Aug. 11 at 3:42 PM
$AMPH covered short on news. Nice profit over last couple years. I’ll be back though bc their sure to f something up 🤣
0 · Reply